Scientists unearth new molecular targets on AT1R that could lead to improved drugs for heart disease

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

When two therapies receive simultaneous approval, there will likely always be one that emerges in the media as a favorite.

Recent research has resulted in a new type of CAR-T therapy that targets non-cancer cells

How many times have you heard phrases like: “gene therapy is a rapidly evolving industry with the potential to transform patients’ lives?”

I hope 2024 brings success to you and your companies – and better health (or even cures) to your patients.

Sterility testing is difficult for autologous cell and gene therapies because of limited volumes and the need for speed.

It’s a good news week: the FDA has approved the first cell therapy to treat unresectable or metastatic melanoma